BiyaPay Analyst: JD Health's Stock Price Increased 50-Fold in 3 Months, Dubbed the "Meme Coin" of the Hong Kong Stock Market

BlockBeats News, September 16th. The stock price of Hong Kong-listed innovative pharmaceutical company Pharmaronix surged over 60% intraday, with a market value approaching HK$270 billion. Since its listing on June 23rd, the stock price has skyrocketed over 50 times in less than three months, being referred to as the "Hong Kong version of a Meme Coin," becoming a new speculative hot spot amid capital frenzy.

The trigger for Pharmaronix's surge was the approval of a clinical trial for its core product, Tengonitinib. This drug is hailed as the "world's first FGFR inhibitor to enter the registered clinical stage," presenting enormous market imagination. However, the company has no commercialized products yet, with a cumulative loss of HK$870 million in three years and no revenue in the first half of 2025. Its "hundred billion market value" seems more like a story-driven by the meme coin frenzy in the crypto market, lacking fundamental support.

BiyaPay analysts pointed out that Pharmaronix's trend is quite similar to meme coins familiar in the crypto community: small circulating supply, strong stimulus from news, and capital inflow driven by emotions. With the push of funds, the stock price experienced a short-term frenzy surge, but whether it can stand firm in the long run remains unknown.

For cryptocurrency investors, this type of Hong Kong stock "new Meme Coin" style market is becoming a new speculative battlefield. Through BiyaPay, users can not only trade BTC, ETH, and other cryptocurrencies with zero fees but also participate in US and Hong Kong stock investments in one place, seize opportunities in "monster stocks" like Pharmaronix, and achieve flexible cross-market allocation.